Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
Authors
Keywords
SARS-CoV-2, COVID-19 testing, COVID-19, Serological Testing, Immunoassay, Spike, Nucleocapsid, IgG
Journal
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Volume -, Issue -, Pages 115659
Publisher
Elsevier BV
Online
2022-02-12
DOI
10.1016/j.diagmicrobio.2022.115659
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
- (2021) Vincent Legros et al. Cellular & Molecular Immunology
- The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers
- (2021) Sheila F Lumley et al. CLINICAL INFECTIOUS DISEASES
- Antibody persistence in the first six months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
- (2021) Arnaud G. L’Huillier et al. CLINICAL MICROBIOLOGY AND INFECTION
- SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline
- (2021) Shelly Bolotin et al. JOURNAL OF INFECTIOUS DISEASES
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Neutralizing antibody titres in SARS-CoV-2 infections
- (2021) Eric H. Y. Lau et al. Nature Communications
- Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers
- (2021) Jan Van Elslande et al. CLINICAL INFECTIOUS DISEASES
- SARS‐CoV‐2 re‐infection risk in Austria
- (2021) Stefan Pilz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
- (2021) Jan Van Elslande et al. JOURNAL OF CLINICAL VIROLOGY
- Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for up to 10 Months after Infection
- (2021) Julien Favresse et al. Microorganisms
- SARS-CoV-2 Antibody Kinetics Eight Months from COVID-19 Οnset: Persistence of Spike Antibodies but Loss of Neutralizing Antibodies in 24% of Convalescent Plasma Donors
- (2021) Evangelos Terpos et al. European Journal of Internal Medicine
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
- (2021) Christian Holm Hansen et al. LANCET
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
- (2021) Carlota Dobaño et al. BMC Medicine
- Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
- (2021) Javier Perez-Saez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study
- (2021) Mar Masiá et al. JOURNAL OF AUTOIMMUNITY
- The fall in antibody response to SARS-CoV-2: a longitudinal study of asymptomatic to critically ill patients up to 10 months after recovery
- (2021) Maddalena Peghin et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study
- (2021) Sabrina Kral et al. JOURNAL OF INFECTION
- Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection
- (2021) Pyoeng Gyun Choe et al. JOURNAL OF INFECTIOUS DISEASES
- Over 1‐year duration and age difference of SARS‐CoV‐2 antibodies in convalescent COVID‐19 patients
- (2021) Fanfan Zeng et al. JOURNAL OF MEDICAL VIROLOGY
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS‐CoV ‐2 antibody persistence in COVID ‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance
- (2021) Clara Di Germanio et al. TRANSFUSION
- Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
- (2021) Floriane Gallais et al. EBioMedicine
- Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
- (2021) Charles F. Schuler et al. Microbiology Spectrum
- Impact of Age and Sex on Antibody Response Following the Second Dose of COVID-19 BNT162b2 mRNA Vaccine in Greek Healthcare Workers
- (2021) Niki Vassilaki et al. Microorganisms
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
- (2021) Laith J. Abu-Raddad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Protective immunity after recovery from SARS-CoV-2 infection
- (2021) Noah Kojima et al. LANCET INFECTIOUS DISEASES
- Waning Immunity after the BNT162b2 Vaccine in Israel
- (2021) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
- (2021) Barak Mizrahi et al. Nature Communications
- Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
- (2021) Margherita Rosati et al. Frontiers in Immunology
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Jiuxin Qu et al. CLINICAL INFECTIOUS DISEASES
- Diagnostic performance of 7 rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
- (2020) Jan Van Elslande et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs
- (2020) Jan Van Elslande et al. CLINICAL MICROBIOLOGY AND INFECTION
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- (2020) AJ Jääskeläinen et al. JOURNAL OF CLINICAL VIROLOGY
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
- (2020) Amin Addetia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search